Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$1.4M Buy
39,810
+430
+1% +$20.5K 0.14% 214
2019
Q4
$2.06M Buy
+39,380
New +$1.96M 0.12% 261
2016
Q3
Sell
-43,385
Closed -$1.5M 745
2016
Q2
$1.5M Sell
43,385
-34,365
-44% -$1.19M 0.04% 323
2016
Q1
$2.68M Sell
77,750
-274,860
-78% -$9.58M 0.08% 216
2015
Q4
$13.6M Sell
352,610
-92,635
-21% -$3.6M 0.36% 87
2015
Q3
$17.4M Buy
445,245
+361,355
+431% +$14.3M 0.49% 66
2015
Q2
$3.19M Sell
83,890
-1,540
-2% -$53.9K 0.09% 170
2015
Q1
$2.82M Buy
+85,430
New +$2.62M 0.08% 188

Other funds holding HOLX

Chicago Equity Partners's HOLX Position: Q1 2020 in Review

Chicago Equity Partners increased its Hologic (HOLX) stake by 1.1% in Q1 2020, buying an estimated $20.5K and bringing the position to 39,810 shares worth $1.4M. The position accounts for 0.14% of the portfolio, ranked #214.

Chicago Equity Partners first reported a position in HOLX in Q1 2015 and has held it in 8 quarters since. The position peaked at $17.4M in Q3 2015. 484 funds tracked by Wall St. Rank hold HOLX as of Q1 2020.

  • Chicago Equity Partners held 39,810 shares of Hologic worth $1.4M as of Q1 2020.
  • Chicago Equity Partners bought 430 Hologic shares in Q1 2020, an estimated $20.5K.
  • Hologic made up 0.14% of Chicago Equity Partners's portfolio in Q1 2020, its #214 holding.
  • Chicago Equity Partners first reported a position in Hologic in Q1 2015 and has held it in 8 quarters since.
  • Chicago Equity Partners's Hologic position peaked at $17.4M in Q3 2015.
  • 484 funds tracked by Wall St. Rank held Hologic as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.